Code: 01431979

COX-2 Blockade in Cancer Prevention and Therapy

Name: COX-2 Blockade in Cancer Prevention and Therapy
Brand: Humana Press Inc.
SKU: 01431979
Price: 127.05 EUR
Availability: InStock

by Randall E. Harris

Language: English
Binding: Paperback
Number of pages: 371
Publisher: Humana Press Inc., 2010
More about this

127.05 €

Low in stock at our supplier
Shipping in 10 - 14 days

Potřebujete více kusů?Máte-li zájem o více kusů, prověřte, prosím, nejprve dostupnost titulu na naši zákaznické podpoře.

Add to wishlist

Human Papillomaviruses
179.30 €
Buy
High-Resolution Sonography of the Peripheral Nervous System
127.05 €
Buy
Slow Potentials and Microprocessor Applications
90.56 €
Buy
Machame Anaesthesia Notebook for Medical Auxiliaries
59.15 €
Buy
Chest, Musculoskeleton, G.I. and Abdomen, Urinary Tract
59.15 €
Buy
Chromosome Atlas: Fish, Amphibians, Reptiles, and Birds
116.58 €
Buy
Ophthalmology at a Glance 2e
41.66 €
Buy

Give this book as a present today

Order book and choose Gift Order.
We will send you book gift voucher at once. You can give it out to anyone.
Book will be send to donee, nothing more to care about.

Book gift voucher sample Read more

More about COX-2 Blockade in Cancer Prevention and Therapy

Book details
Synopsis
Trending among others

You get 316 loyalty points

Book synopsis

The discovery that aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) have notable antineoplastic properties has revolutionized cancer research. In COX-2 Blockade in Cancer Prevention and Therapy, a panel of leading experts chronicles the evidence for the chemopreventive and therapeutic effects of cyclooxygenase-2 (COX-2) inhibitors against virtually all forms of cancer and presents exciting new opportunities for the use of COX-2 blockade in their prevention and treatment. These highly experienced authors elucidate the process by which COX-2 inhibitors interrupt prostaglandin biosynthesis and cancer development, examine the positive epidemiological effects of such NSAIDs as aspirin and ibuprofen on various cancers, and demonstrate through animal models that NSAIDs inhibit a variety of malignant neoplasms in vivo. They also present genetic models confirming the critical role of COX-2 in carcinogenesis and discuss how its molecular biology modulates carcinogenesis via such processes as mutagenesis, cell division, angiogenesis, cell differentiation, and apoptosis. In addition, the authors review the clinical applications of selected NSAIDs that are immediately relevant to cancer prevention and control and outline the future prospects of COX-2 blocking agents.§Comprehensive and up-to-date, COX-2 Blockade in Cancer Prevention and Therapy demonstrates how COX-2 inhibitors and other NSAIDs reduce the risk of most cancers and provides cancer investigators today with a clear and authoritative guide to the development of novel agents with significant antineoplastic properties.This book chronicles the evidence for the chemopreventive and therapeutic effects of cyclooxygenase-2 (COX-2) inhibitors against virtually all forms of cancer and presents exciting new opportunities for the use of COX-2 blockade in its prevention and treatment. The authors elucidate the process by which COX-2 inhibitors interrupt prostaglandin biosynthesis and cancer development, examine the positive epidemiological effects of such NSAIDs as aspirin and ibuprofen on various cancers, and demonstrate through animal models that COX-2 inhibitors and NSAIDs inhibit a variety of malignant neoplasms in vivo. They also present genetic models confirming the critical role of COX-2 in carcinogenesis and discuss how its molecular biology modulates carcinogenesis. In addition, the authors review the clinical applications of selected NSAIDs that are immediately relevant to cancer prevention and control and outline the future prospects of COX-2 blocking agents.